Odyssey Therapeutics, Inc. ODTX
19.35 USD -0.02 (-0.10%)
As ofNov 18, 2026, 10:38 AM EST
19.26 Day range 19.83
15.10 52-week range 29.05
- YTD
- +17.84%
- 1 year
- +17.84%
News
benzinga.com Odyssey Therapeutics Publishes Paper Titled 'TNFR2 agonism increases tissue and effector Treg cells In Journal Of Immunology Odyssey Therapeutics, Inc. (Nasdaq: ODTX) ("Odyssey" or the "Company"), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and
benzinga.com HC Wainwright & Co. Assumes Odyssey Therapeutics at Buy, Announces Price Target of $40 HC Wainwright & Co. analyst Joseph Pantginis assumes Odyssey Therapeutics (NASDAQ:ODTX) with a Buy rating and announces Price Target of $40.
benzinga.com Odyssey Therapeutics Q3 EPS $(1.10) Misses $(1.08) Estimate Odyssey Therapeutics (NASDAQ:ODTX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(1.08) by 1.85 percent.
